Similar articles

• Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  Cascinu S, Falconi M, Valentini V, Jelic S; ESMO Guidelines Working Group. Cascinu S, et al. Ann Oncol. 2010 May;21 Suppl 5:v55-8. doi: 10.1093/annonc/mdq165. Ann Oncol. 2010. PMID: 20555103 No abstract available.
• Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647].

  Chen LT, Vogel A, Hsu C, Chen MH, Fang W, Pangarsa EA, Sharma A, Ikeda M, Park JO, Tan CK, Regala E, Tai D, Tanasanvimon S, Charoentum C, Chee CE, Lui A, Sow J, Oh DY, Ueno M, Ramaswamy A, Jeo WS, Zhou J, Curigliano G, Yoshino T, Bai LY, Pentheroudakis G, Chiang NJ, Cervantes A, Chen JS, Ducreux M. Chen LT, et al. ESMO Open. 2025 Jan;10(1):104074. doi: 10.1016/j.esmoop.2024.104074. Epub 2024 Dec 19. ESMO Open. 2025. PMID: 39864890 Free PMC article. No abstract available.
• Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  Cascinu S, Jelic S; ESMO Guidelines Working Group. Cascinu S, et al. Ann Oncol. 2009 May;20 Suppl 4:37-40. doi: 10.1093/annonc/mdp123. Ann Oncol. 2009. PMID: 19454458 Review. No abstract available.
• Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N; ESMO Guidelines Committee. Marth C, et al. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv262. doi: 10.1093/annonc/mdy160. Ann Oncol. 2018. PMID: 29741577 No abstract available.
• Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework.

  de Hosson LD, van Veenendaal LM, Schuller Y, Zandee WT, de Herder WW, Tesselaar MET, Klümpen HJ, Walenkamp AME. de Hosson LD, et al. Ann Oncol. 2017 Dec 1;28(12):3022-3027. doi: 10.1093/annonc/mdx547. Ann Oncol. 2017. PMID: 29045525 Review.